The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 22,964,194 | 16,640,720 | SH | OTR | 1,2,3,4 | 0 | 16,640,720 | 0 | |
| CENTURY THERAPEUTICS | Common Stock | 15673T100 | 2,741,507 | 1,213,056 | SH | OTR | 1,2,3,4 | 0 | 1,213,056 | 0 | |